Gastrointestinal Neuroendocrine Carcinoma
2 clinical trials · Condition
◉ Watch Gastrointestinal Neuroendocrine Carcinoma
| Record | Firm | Date |
|---|---|---|
| Multicenter Trial of ESK981 in Patients With Select Solid Tumors (NCT05988918) | University of Michigan Rogel Cancer Center | 2024-04-19 |
| First- Line Treatment With Durvalumab Plus XELOX Chemotherapy in Advanced Gastrointestinal Neuroendocrine Carcinoma (NCT06070740) | Peking Union Medical College Hospital | 2023-11-01 |
Track Gastrointestinal Neuroendocrine Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.